WEDNESDAY, July 1, 2020 (HealthDay News) -- Scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year. A single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six m…